Recombinant chemokine-antigen vaccine

Details for Australian Patent Application No. 2005240691 (hide)

Owner Cancer Institute, Chinese Academy of Medical Sciences

Inventors Wang, Dongmei; Ma, Wenbo; Qin, Hanjun; Lin, Chen; Liang, Xiao; Sun, Wenxin; Zhou, Chunxia; Zhang, Shuren; Fu, Ming; Zhang, Xueyan

Agent Davies Collison Cave

Pub. Number AU-B-2005240691

PCT Pub. Number WO2005/108584

Priority 200410037910.3 10.05.04 CN

Filing date 9 May 2005

Wipo publication date 17 November 2005

Acceptance publication date 4 June 2009

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C12N 15/19 (2006.01) Mutation or genetic engineering - Interferons

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/108584 Priority application(s): WO2005/108584

26 April 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Tan, Hanjun to Qin, Hanjun

11 October 2007 Assignment before Grant

  Dongguan Haofa Bio-Engineering Development Co., Ltd. The application has been assigned to Cancer Institute, Chinese Academy of Medical Sciences

4 June 2009 Application Accepted

  Published as AU-B-2005240691

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240714-GM3 synthase as a therapeutic target in microvascular complications of diabetes

2005240686-Self-energizing brake system